{
  "guideline": {
    "id": "PA166182817",
    "name": "Annotation of DPWG Guideline for citalopram, escitalopram and CYP2D6",
    "relatedChemicals": [
      {
        "id": "PA449015",
        "name": "citalopram",
        "symbol": null
      },
      {
        "id": "PA10074",
        "name": "escitalopram",
        "symbol": null
      }
    ],
    "relatedGenes": [
      {
        "id": "PA128",
        "name": "cytochrome P450 family 2 subfamily D member 6",
        "symbol": "CYP2D6"
      }
    ],
    "source": "DPWG",
    "recommendation": false,
    "guidelineGenes": [],
    "@id": "https://pharmgkb.org/guidelineAnnotation/PA166182817",
    "version": 7
  },
  "annotationGroups": [],
  "citations": [
    {
      "pmid": "34782755",
      "title": "Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C19 and CYP2D6 and SSRIs.",
      "authors": [
        "Brouwer Jurriaan M J L",
        "Nijenhuis Marga",
        "Soree Bianca",
        "Guchelaar Henk-Jan",
        "Swen Jesse J",
        "van Schaik Ron H N",
        "Weide Jan van der",
        "Rongen Gerard A P J M",
        "Buunk Anne-Marie",
        "de Boer-Veger Nienke J",
        "Houwink Elisa J F",
        "van Westrhenen Roos",
        "Wilffert Bob",
        "Deneer Vera H M",
        "Mulder Hans"
      ],
      "journal": "European journal of human genetics : EJHG",
      "year": 2021
    }
  ]
}